Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 200 Total
FRLN - Freeline Therapeutics Holdings plc ADR - Stock Price Chart
CompanyFreeline Therapeutics Holdings plc ADR
CountryUnited Kingdom
Market Cap18.88MEPS (ttm)-12.16
P/E-EPS this Y95.71%
Forward P/E-EPS next Y1.60%
PEG-EPS past 5Y-
P/S30.45EPS next 5Y-
P/B0.45EPS Q/Q33.85%
Dividend-Sales Q/Q-
Insider Own4.96%Inst Own53.82%
Insider Trans0.00%Inst Trans-1.73%
Short Float2.49%EarningsAug 15/b
Analyst Recom1.50Target Price9.50
Avg Volume365.06K52W Range2.11 - 12.00
Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Horer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom.
PPBT - Purple Biotech Ltd ADR - Stock Price Chart
CompanyPurple Biotech Ltd ADR
Market Cap24.16MEPS (ttm)-1.07
P/E-EPS this Y21.67%
Forward P/E-EPS next Y34.40%
PEG-EPS past 5Y38.17%
P/S-EPS next 5Y-
P/B0.57EPS Q/Q-23.67%
Dividend-Sales Q/Q-
Insider Own0.10%Inst Own1.30%
Insider Trans0.00%Inst Trans-12.56%
Short Float3.08%EarningsAug 22/b
Analyst Recom1.00Target Price10.00
Avg Volume84.02K52W Range1.01 - 2.37
Purple Biotech Ltd. is a development stage pharmaceutical company, which engages in drug development. It operates through two segments: Oncology, and Pain & Hypertension. The Oncology segment includes NT219, a therapeutic candidate which is a small molecule that targets two signal transduction pathways which are involved in the development of cancer drug resistance mechanisms, and which is currently in the late pre-clinical stage of development. The Pain & Hypertension segment includes Consensi, a combination drug for the simultaneous treatment of two clinical conditions, pain caused by osteoarthritis and hypertension (high blood pressure), which can be pre-existing or caused by the treatment for osteoarthritis. The company was founded by John Paul Waymack on August 12, 1968 and is headquartered in Rehovot, Israel.
IHS - IHS Holding Ltd - Stock Price Chart
TickerIHS [NYSE]
CompanyIHS Holding Ltd
CountryUnited Kingdom
IndustryTelecom Services
Market Cap1.92BEPS (ttm)-4.60
P/E-EPS this Y-108.99%
Forward P/E8.37EPS next Y-
PEG-EPS past 5Y-36.44%
P/S0.87EPS next 5Y-
P/B3.73EPS Q/Q-603.46%
Dividend-Sales Q/Q16.79%
Insider Own63.59%Inst Own19.16%
Insider Trans0.00%Inst Trans-0.27%
Short Float0.39%EarningsAug 15/b
Analyst Recom1.12Target Price17.64
Avg Volume340.77K52W Range4.51 - 10.13
IHS Holding Ltd. provides mobile telecommunications infrastructure services. It operates through the following geographical segments: Nigeria, Sub-Saharan Africa (SSA), Middle East and North Africa (MENA), Latin America(Latam), and Other. The SSA segment operates in Cameroon, Cote d'Ivoire, Rwanda and Zambia. The Latam segment consists of Brazil, Colombia and Peru. The MENA segment focuses in Kuwait and Egypt operations. The company was founded by Issam Darwish, William S. Saad, and Mohamad Darwish in 2001 and is headquartered in London, the United Kingdom.
MAIA - MAIA Biotechnology Inc - Stock Price Chart
CompanyMAIA Biotechnology Inc
Market Cap21.98MEPS (ttm)-1.59
P/E-EPS this Y12.57%
Forward P/E-EPS next Y-5.88%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B3.20EPS Q/Q12.94%
Dividend-Sales Q/Q-
Insider Own36.62%Inst Own2.36%
Insider Trans4.64%Inst Trans394.27%
Short Float0.24%EarningsAug 08/b
Analyst Recom1.00Target Price12.62
Avg Volume28.77K52W Range1.42 - 5.22
MAIA Biotechnology, Inc. is a clinical stage biotechnology company that is engaged in the discovery, development and commercialization of therapies targeting cancer. Its product, THIO, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. The company was founded on August 3, 2018 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Guerrero RamiroDirectorMay 18Buy2.471,2002,964312,672May 22 06:49 AM
Luput CristianDirectorMay 15Buy2.633,0007,890298,068May 17 06:55 AM
Vitoc VladChief Executive OfficerApr 28Buy2.504,00010,000809,121May 01 06:30 AM
Smith StanDirectorApr 27Buy2.25133,300299,925686,628Apr 28 06:46 AM
Louie Ngar YeeDirectorApr 27Buy2.2548,000108,000976,584Apr 28 06:49 AM
ADAG - Adagene Inc ADR - Stock Price Chart
CompanyAdagene Inc ADR
Market Cap65.74MEPS (ttm)-0.87
P/E-EPS this Y-21.01%
Forward P/E-EPS next Y-39.82%
PEG-EPS past 5Y-54.53%
P/S2.88EPS next 5Y-
P/B0.79EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own6.24%Inst Own3.19%
Insider Trans0.00%Inst Trans-20.24%
Short Float0.06%EarningsAug 31/b
Analyst Recom1.00Target Price15.50
Avg Volume19.80K52W Range0.90 - 2.10
Adagene, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.
NINE - Nine Energy Service Inc - Stock Price Chart
CompanyNine Energy Service Inc
IndustryOil & Gas Equipment & Services
Market Cap161.90MEPS (ttm)0.43
P/E10.77EPS this Y-
Forward P/E-EPS next Y86.36%
PEG-EPS past 5Y-
P/S0.25EPS next 5Y-
P/B-EPS Q/Q-140.38%
Dividend-Sales Q/Q13.41%
Insider Own18.88%Inst Own57.67%
Insider Trans-8.28%Inst Trans10.84%
Short Float6.39%EarningsAug 03/a
Analyst Recom2.00Target Price6.00
Avg Volume963.27K52W Range2.34 - 17.10
Nine Energy Service, Inc. is an oilfield services business, which engages in the provision of services integral to the completion of unconventional wells. It offers cementing services, completion tools, wireline services, and coiled tubing services. The company was founded on September 26, 2011 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Crombie DavidSee RemarksAug 11Sale4.6040,657187,022209,075Aug 14 05:49 PM
MOORE THEODORE R.See RemarksAug 11Sale4.6722,221103,772115,725Aug 14 05:43 PM
Fox Ann GSee RemarksAug 09Sale4.9037,527183,882725,487Aug 11 04:34 PM
Crombie DavidSee RemarksAug 09Sale4.9025,386124,391249,732Aug 11 04:34 PM
Sirkes GuySee RemarksAug 09Sale4.9014,32270,178134,627Aug 11 04:37 PM
VIST - Vista Energy S.A.B. de C.V ADR - Stock Price Chart
CompanyVista Energy S.A.B. de C.V ADR
IndustryOil & Gas E&P
Market Cap2.82BEPS (ttm)3.32
P/E9.15EPS this Y50.79%
Forward P/E5.60EPS next Y28.23%
PEG-EPS past 5Y-
P/S2.40EPS next 5Y-
P/B2.83EPS Q/Q-51.03%
Dividend-Sales Q/Q-21.52%
Insider Own1.08%Inst Own46.30%
Insider Trans0.00%Inst Trans-
Short Float3.53%EarningsJul 14/b
Analyst Recom1.00Target Price16.23
Avg Volume666.38K52W Range8.43 - 28.64
Vista Energy SAB de CV is an oil and gas company, which engages in the exploration and production of oil and gas. It operates through Argentina and Mexico geographical segments. The firm's assets include Vaca Muerta, the largest shale oil and gas play under development outside North AMerica. The company was founded on March 22, 2017 and is headquartered in Alcaldia Miguel Hidalgo, Mexico.
MKFG - Markforged Holding Corporation - Stock Price Chart
CompanyMarkforged Holding Corporation
IndustryComputer Hardware
Market Cap282.17MEPS (ttm)-0.37
P/E-EPS this Y14.11%
Forward P/E-EPS next Y18.22%
PEG-EPS past 5Y-
P/S2.70EPS next 5Y-
P/B1.29EPS Q/Q-
Dividend-Sales Q/Q5.04%
Insider Own48.82%Inst Own38.81%
Insider Trans0.16%Inst Trans1.19%
Short Float3.73%EarningsAug 10/a
Analyst Recom1.40Target Price2.34
Avg Volume1.53M52W Range0.71 - 2.30
Markforged Holding Corp. engages in manufacturing, producing, and selling 3D printers and materials worldwide to customers. The company was founded in 2013 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zipori AssafActing Chief Financial OfficerMay 24Buy1.0350,00051,420368,996May 26 09:45 AM
Terem ShaiChief Executive OfficerMay 22Buy0.97100,00097,3502,234,842May 23 06:10 AM
Schwartz Mark JosephChief Financial OfficerMar 14Sale0.9730,00029,1001,023,446Mar 16 04:15 PM
Schwartz Mark JosephChief Financial OfficerNov 15Sale1.7128,64148,9761,081,024Nov 16 04:05 PM
Schwartz Mark JosephChief Financial OfficerNov 14Sale1.7051,35987,4241,109,665Nov 16 04:05 PM
ACRV - Acrivon Therapeutics Inc - Stock Price Chart
CompanyAcrivon Therapeutics Inc
Market Cap217.17MEPS (ttm)-2.08
P/E-EPS this Y64.05%
Forward P/E-EPS next Y-24.37%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.46EPS Q/Q-83.19%
Dividend-Sales Q/Q-
Insider Own47.81%Inst Own62.73%
Insider Trans-0.08%Inst Trans-
Short Float2.80%EarningsAug 11/b
Analyst Recom1.00Target Price24.00
Avg Volume13.08K52W Range8.06 - 25.47
Sep-19-23 04:32PM Acrivon Therapeutics to Highlight its ACR-368 OncoSignature Test, Used in Ongoing Phase 2 Study to Treat Patients Based on Predicted Sensitivity to Monotherapy with its CHK1/2 Inhibitor ACR-368, at the Upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics (GlobeNewswire)
Sep-05-23 04:05PM Acrivon Therapeutics Announces ACR-2316, a Novel Dual WEE1 and PKMYT1 Inhibitor Development Candidate, Designed Using Acrivons AP3 Platform to Achieve Potent Single Agent Activity, as Demonstrated in Preclinical Studies (GlobeNewswire)
Aug-30-23 08:00AM Acrivon Therapeutics to Participate in Two Investor Conferences in September (GlobeNewswire)
Aug-17-23 04:00PM Acrivon Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-11-23 07:00AM Acrivon Therapeutics Reports Second Quarter 2023 Financial Results and Business Highlights (GlobeNewswire) +6.81%
Aug-08-23 12:38PM Q2 2023 Akoya Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Jul-20-23 08:00AM Acrivon Therapeutics Announces the Appointment of Adam Levy, Ph.D., M.B.A., Experienced Biotech Investor Relations and Strategy Executive, to Senior Vice President and Head, Investor Relations and Corporate Affairs (GlobeNewswire)
Jun-29-23 04:49PM 7 Up-and-Coming Stocks to Buy for the Next Decade (InvestorPlace)
Jun-22-23 04:00PM Acrivon Therapeutics Announces the Appointment of Seasoned Biopharma Executive Charles Baum, M.D., Ph.D., a Recognized Leader in Clinical Precision Oncology, to its Board of Directors (GlobeNewswire)
Jun-02-23 08:00AM Acrivon Therapeutics to Present at the Jefferies Healthcare Conference (GlobeNewswire)
Acrivon Therapeutics, Inc. develops drugs for clinical treatment. Its unique precision medicine platform is Acrivon Predictive Precision Proteomics (AP3). AP3 is used to generate proprietary OncoSignature companion diagnostics to identify patients who will benefit from the medicine. The company was founded by Peter Blume-Jensen and Kristina Masson in 2018 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Chione Ltd10% OwnerJun 26Sale12.93162073,848,632Jun 28 03:47 PM
Holm-Jorgensen RasmusChief Financial OfficerJun 16Option Exercise3.639,50034,48529,530Jun 20 05:21 PM
Chione Ltd10% OwnerJun 15Sale12.142,05624,9603,848,648Jun 20 05:15 PM
Chione Ltd10% OwnerJun 14Sale12.1389310,8323,850,704Jun 14 06:33 PM
Chione Ltd10% OwnerJun 13Sale12.303,00036,9003,851,597Jun 14 06:33 PM
ADD - Color Star Technology Co Ltd - Stock Price Chart
TickerADD [NASD]
CompanyColor Star Technology Co Ltd
Market Cap13.88MEPS (ttm)-100.83
P/E-EPS this Y0.00%
Forward P/E-EPS next Y28.57%
PEG-EPS past 5Y36.64%
P/S1.96EPS next 5Y20.00%
P/B0.32EPS Q/Q-
Dividend-Sales Q/Q28.55%
Insider Own6.39%Inst Own5.47%
Insider Trans0.00%Inst Trans69.97%
Short Float5.26%Earnings-
Analyst Recom-Target Price-
Avg Volume47.73K52W Range0.65 - 2.78
Color Star Technology Co., Ltd. is an entertainment technology company, which focuses on the application of technology and artificial intelligence in the entertainment industry. The firm offers a professional artist training platform that features exclusive content and live interaction. Its courses are focused on music, sports, animation, painting and calligraphy, film and television, and life skills. The company was founded in 2002 and is headquartered in New York, NY.